Research PaperResearchia:202604.10003
CRISPR-Cas12a Gene Editing of <i>HBG1</i> and <i>HBG2</i> Promoters to Treat Sickle Cell Disease
Rabi Hanna
Abstract
CRISPR-Cas12a Gene Editing of <i>HBG1</i> and <i>HBG2</i> Promoters to Treat Sickle Cell Disease --- Source: OpenAlex - New England Journal of Medicine (Citations: 3) PDF: N/A Original Link: https://doi.org/https://doi.org/10.1056/nejmoa2415550
Submitted: April 10, 2026Subjects: Open Science; Genome editing
Description / Details
CRISPR-Cas12a Gene Editing of <i>HBG1</i> and <i>HBG2</i> Promoters to Treat Sickle Cell Disease
Source: OpenAlex - New England Journal of Medicine (Citations: 3) PDF: N/A Original Link: https://doi.org/https://doi.org/10.1056/nejmoa2415550
Please sign in to join the discussion.
No comments yet. Be the first to share your thoughts!
Access Paper
Submission Info
Date:
Apr 10, 2026
Apr 10, 2026
Topic:
Genome editing
Genome editing
Area:
Open Science
Open Science
Comments:
0
0
Bookmark